Today, Respiratory Technology Corporation (Restech) is pleased to announce the signing of distribution partnership agreements with eight distributors. These new strategic partnerships position Restech to meet the increased demand for its Restech Dx-pH Measurement System in Malaysia, United Kingdom, Germany, Italy, Switzerland, Greece, Poland, the Netherlands, Belgium, and Luxembourg.
Restech’s Dx-pH System provides valuable information about patients’ acid exposure and its role in various comorbidities, helping physicians diagnose the cause of the patient’s symptoms more accurately, and treat the patient more effectively.
The distributors will develop relationships with physicians, medical offices, and hospitals to supply Dx-pH Systems and will focus on providing them with professional and efficient customer service. The new global network of distributors was selected for their expertise in the medical industry and outstanding market coverage. The new network includes ATOS Medical (Benelux), Neuwirth Medical (Germany), Intel Med (Greece), Arkon S.R.I. (Italy), MKS Medic, (Malaysia), Provita Medical Equipment (Poland), Promedics GmbH (Switzerland), and Ardmore Healthcare (United Kingdom).
Commenting on the agreements, Jonathon Sayre, Esq., Director, Business and Legal Affairs, Restech, said: “Acquiring these major distributors represents Restech’s commitment to expansion and increasing our global reach. The relationships we have created with these distributors will support our goal of making available Restech’s Dx-pH System for the detection of pH readily available to physicians around the world. We are extremely excited about these new opportunities as we set our sights on what the coming years will bring for all of us.”
Thomas Ball, European Sales Manager, Restech, concurred, saying: “With the dramatic increase of patients presenting symptoms of acid reflux, an accurate diagnosis is critical for physicians to provide appropriate treatment. It is important that we support the medical communities with highly respected local distributors. They are the ideal partners for this exciting stage of our global development.”
The Restech Dx–pH Measurement System is a revolutionary system that comfortably measures pH in the airway.
Gastric reflux in the upper airway, or laryngopharyngeal reflux, commonly takes a gaseous form that cannot be measured using conventional technology. The miniaturized pH sensor at the tip of the Dx–pH Probe is unique in its ability to measure pH in a non-liquid environment, such as the pharynx. By monitoring the pH levels in the pharynx, the Dx–System enables physicians to confirm or deny the presence of laryngopharyngeal reflux, and evaluate it as a possible contributor to their patients’ symptoms.
Restech is a leader in engineering world class medical technologies that provide comfortable, reliable solutions to assist physicians in the diagnosis of reflux related health problems quickly and reliably.
The innovative engineering team at Restech is led by professionals with over two decades experience each in medical device development. Together, the Restech staff holds over 30 patents in the areas of sensor technology, data recording & monitoring systems, and medical devices.
For more information on the Dx-pH Measurement System, please contact Ms. Debra Krahel of Restech (+1-858-673-3700 or firstname.lastname@example.org), or visit http://www.restech.com.